Biological medicines present analytical challenges that are very different from those of conventional drugs. Therapeutic proteins and monoclonal antibodies have complex structures whose identity, integrity and potential modifications must be studied using highly precise techniques. In this context, peptide mapping has become a fundamental tool for gaining detailed insight into the composition of a protein and assessing certain attributes related to its structure.
This technique provides a kind of molecular fingerprint of a protein, offering information about its sequence and certain modifications that may affect its characteristics.
What is peptide mapping?
Peptide mapping is an analytical technique used to characterize proteins by controlled fragmentation into smaller peptides. These fragments can subsequently be separated, detected and identified to obtain detailed information about the protein being analyzed.
The procedure usually begins with sample preparation. Depending on the method used, denaturation, reduction and alkylation steps may be performed to facilitate enzyme access to certain regions of the protein.
An enzymatic digestion is then carried out. Trypsin is one of the most widely used proteases because it preferentially cleaves polypeptide chains at positions associated with lysine and arginine residues, generating fragments suitable for subsequent analysis.
The resulting set of peptides constitutes a characteristic pattern that can be compared with the theoretical protein sequence or with a reference material.
In this way, peptide mapping makes it possible to study the identity and primary structure of a protein with a higher level of detail than that provided by a determination of its overall mass.
How does peptide mapping work?
Peptide mapping comprises several stages that must be carefully controlled to obtain reproducible results.
In simplified terms, the process can be divided into the following steps:
- Sample preparation: the protein is prepared to facilitate its analysis.
- Denaturation, reduction and alkylation: when required by the method, these steps modify the protein structure and facilitate digestion.
- Enzymatic digestion: a protease, such as trypsin, fragments the protein into peptides.
- Peptide separation: usually performed by liquid chromatography.
- Detection and identification: the peptides can be analyzed using mass spectrometry.
- Data analysis: experimental results are compared with the expected sequence to identify peptides and assess sequence coverage.
The final result provides a characteristic profile that can be used to compare samples and detect potential differences.
Mass spectrometry increases the level of detail
Although different approaches can be used to perform peptide mapping, one of the most widely used combinations is liquid chromatography coupled with mass spectrometry, using LC-MS or LC-MS/MS systems.
Liquid chromatography separates the peptides generated during digestion, while the mass spectrometer provides information about their mass and composition.
In MS/MS analyses, certain ions can be fragmented further. These fragments provide additional information that facilitates the assignment of peptide sequences.
This combination enables a much more specific characterization than a simple determination of the overall molecular mass of the protein.
In addition, computational data processing allows experimental results to be compared with the expected sequence and the detected peptides to be identified.
One of the parameters that can be assessed is sequence coverage, which refers to the percentage of the protein sequence represented by the identified peptides. Higher coverage can provide a more complete view of the primary structure being analyzed.
Why is peptide mapping important for biologics?
A biological molecule is not defined solely by its chemical formula. Its manufacturing, purification and storage processes can influence different molecular attributes.
Peptide mapping helps confirm the identity of a protein and determine whether the analyzed sequence matches the expected sequence. This is particularly relevant for monoclonal antibodies, recombinant proteins and other biopharmaceutical products.
Peptide mapping can also be used to:
- Compare different batches of a product.
- Investigate potential deviations during manufacturing.
- Study changes associated with stability.
- Characterize recombinant proteins.
- Analyze monoclonal antibodies.
- Compare products during biosimilar development.
- Investigate certain chemical or post-translational modifications.
For this reason, peptide mapping is a relevant tool at different stages of the development, characterization and quality control of biological products.
What modifications can peptide mapping detect?
Proteins can undergo post-translational modifications or chemical alterations. Some are part of the natural characteristics of the product, while others may occur during manufacturing, handling or storage.
Phenomena that can be studied using peptide mapping strategies include:
- Oxidation.
- Deamidation.
- Certain amino acid modifications.
- Changes associated with degradation processes.
- Other chemical modifications that alter peptide mass.
Detecting a modification does not automatically mean that there is a problem with the product. Its identity, abundance, location and potential relationship with other critical quality attributes must be assessed.
Therefore, having sufficiently sensitive and reproducible methods that are appropriately validated or qualified according to their intended purpose is essential for correctly interpreting the results.
Peptide mapping and biosimilar development
The development of biosimilars has increased the importance of advanced analytical characterization techniques.
Unlike a chemical drug with a relatively simple structure, the comparison of biological products requires the study of a broad range of structural and functional characteristics.
In this context, peptide mapping contributes to the study of the primary structure and certain molecular attributes of a biosimilar candidate compared with its reference biological product. These aspects form part of the analytical characterization considered in EMA guidelines for similar biological medicinal products.
However, peptide mapping should not be considered an isolated test. The characterization of a biological product typically integrates different analytical techniques, including chromatographic, electrophoretic and spectroscopic methods, mass spectrometry and functional assays.
Combining these techniques provides a more comprehensive view of the product and its quality attributes.
Sample preparation is also key
Having advanced instrumentation does not eliminate the need to carefully control the steps preceding the analysis.
In a peptide mapping study, factors such as temperature, pH, digestion time, enzyme concentration and reduction conditions can influence the results.
Incomplete digestion can generate unexpected peptides due to cleavage sites that have not been cleaved. On the other hand, overly aggressive conditions may promote the formation of artificial modifications during sample preparation.
For this reason, the sample preparation protocol must be carefully designed and controlled. Reproducibility is particularly important when different samples, batches or stability conditions are being compared.
What information does a peptide mapping analysis provide?
Peptide mapping can provide relevant information about different aspects of a protein.
These include peptide identification, sequence coverage and the detection of certain modifications. When combined with mass spectrometry, it can also provide additional information to confirm the identity of the analyzed fragments.
This information makes it possible to build a molecular profile of the protein and compare it with a theoretical sequence or a reference material.
However, it is important to interpret the results within the context of the study. Peptide mapping provides highly valuable information, but it should be complemented by other analytical techniques to achieve a comprehensive characterization of the biological product.
Peptide mapping: a key tool for protein characterization
Peptide mapping enables proteins to be studied through the generation and analysis of peptide fragments, providing detailed information about their sequence and certain modifications.
Its combination with techniques such as LC-MS and LC-MS/MS offers a particularly useful level of characterization for therapeutic proteins, monoclonal antibodies and other biopharmaceutical products.
It can also play an important role in batch comparison, the investigation of changes during storage and the characterization of biosimilar candidates.
However, the quality of the results depends not only on the instrumentation but also on sample preparation, method design and subsequent data processing.
Therefore, peptide mapping should be understood as part of a broader analytical strategy in which different techniques complement one another to provide robust characterization of biological products.
Frequently Asked Questions
- What is peptide mapping? Peptide mapping is an analytical technique used to characterize proteins. It involves fragmenting a protein into smaller peptides through enzymatic digestion and subsequently analyzing these fragments to obtain information about their sequence and certain modifications.
- What is peptide mapping used for? Peptide mapping is primarily used to study the identity and primary structure of proteins. It can also be used to compare samples or batches and to investigate certain chemical or post-translational modifications.
- What enzyme is commonly used in peptide mapping? Trypsin is one of the most widely used enzymes in peptide mapping because it generates peptides that are suitable for subsequent analysis using chromatographic techniques and mass spectrometry.
- What is the relationship between peptide mapping and mass spectrometry? Mass spectrometry allows the peptides generated during peptide mapping to be analyzed. When LC-MS or LC-MS/MS is used, chromatographic separation can be combined with mass and fragmentation information to facilitate peptide identification.
